Concord Biosciences Overview

  • Founded
  • 1986
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 200
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 7
  • Investments
  • 2

Concord Biosciences General Information

Description

Provider of contract research and chemical development services. The company's services offers comprehensive capabilities and conducts studies with all species commonly used in nonclinical research providing study information with insightful analysis enabling its clients in the Agricultural Chemicals industry with a comprehensive, integrated suite of services to accelerate drug development through all phases of drug development.

Contact Information

Formerly Known As
Ricerca Biosciences
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Specialty Chemicals
Pharmaceuticals
Primary Office
  • 10845 Wellness Way
  • Concord, OH 44077
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Concord Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Concord Biosciences‘s full profile, request access.

Request a free trial

Concord Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of contract research and chemical development services. The company's services offers comprehensive capabilitie
Drug Discovery
Concord, OH
200 As of 2014
00.00
000000&0

000 000

ptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proid
000000000000000
Zug, Switzerland

000

dipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim
0000 000000000
Chapel Hill, NC
000 As of 0000
0000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Concord Biosciences Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PSI CRO Corporation Zug, Switzerland
000 Corporation Chapel Hill, NC 000 0000000000
0000000 Private Equity-Backed Ann Arbor, MI 00000 0000000 0000
000000 Private Equity-Backed Hyderabad, India 0000 0000 00000000000 0000
00000000000000 000 Formerly PE-Backed Wilmington, NC 00000 00.000 000000&0 00.000
You’re viewing 5 of 5 competitors. Get the full list »

Concord Biosciences Patents

Concord Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20070082920-A1 Nad+-dependent dna ligase inhibitors Abandoned 06-Oct-2005 0000000000 0
US-20040248877-A1 Inducing apoptosis in tumor cells Abandoned 30-Apr-2003 0000000000 00
US-20040242886-A1 Induction apoptosis in tumor cells; antitumor, anticancer agents Abandoned 30-Apr-2003 C07D213/89 00

Concord Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Concord Biosciences Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Concord Biosciences‘s full profile, request access.

Request a free trial

Concord Biosciences Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 01-Aug-2010 00000 0000 Drug Discovery
MDS (Discovery & Pre-clinical Operations) 08-Mar-2010 Buyout/LBO 000.00 Drug Delivery 000 00000
To view Concord Biosciences’s complete investments history, request access »

Concord Biosciences Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 01-Aug-2010 00000 00000 00 Completed
  • 3 buyers
To view Concord Biosciences’s complete exits history, request access »